Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor. (Q48644058)
Jump to navigation
Jump to search
scientific article published in July 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor. |
scientific article published in July 2016 |
Statements
1 reference
Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor. (English)
1 reference
Margaret von Mehren
1 reference
Phillip Zook
1 reference
Harsh B Pathak
1 reference
Martin G Belinsky
1 reference
Lawrence Gersz
1 reference
Karthik Devarajan
1 reference
Yan Zhou
1 reference
Andrew K Godwin
1 reference
Lori Rink
1 reference
1 July 2016
1 reference
1 reference
23
1 reference
1
1 reference
171-180
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference